VAERS reports by lot

GSK Varicella/Shingles lot 7BC47: VAERS reports

30 VAERS reports list lot 7BC47 as a GSK Varicella/Shingles vaccine, received between 2022-04-09 and 2022-11-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2428%
Dermatological (non-injection-site)1315%
Neurological1011%
Gastrointestinal89%
General / Systemic (non-local)78%
Allergic / Anaphylactic67%
Musculoskeletal67%
Cardiac / Cardiovascular56%
Respiratory56%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina6
New Jersey4
South Carolina4
Virginia3
Michigan2
Maine1
New York1
Massachusetts1
Arizona1
California1
Maryland1
Kentucky1

Reports by month received

2022-043
2022-053
2022-062
2022-076
2022-0811
2022-092
2022-102
2022-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.